Dr. Lal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
6 Founders
Philadelphia, PA 19104Phone+1 215-662-6503
Summary
- Dr. Priti Lal is a pathologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Penn Presbyterian Medical Center, Hospital of the University of Pennsylvania, and Pennsylvania Hospital. She received her medical degree from Maulana Azad Medical College and has been in practice 16 years. She specializes in genitourinary pathology, molecular genetics, anatomic pathology, and surgical pathology. She has more than 100 publications and over 500 citings.
Education & Training
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2000 - 2001
- New Jersy Medical School - University of Medicine and DentistryChief Residency, 1999 - 2000
- Rutgers Health/New Jersey Medical SchoolResidency, Pathology-Anatomic and Clinical, 1995 - 2000
- NIA, NIHPost-Doctoral Fellowship, 1993 - 1995
- National Cancer InstitutePost-Doctoral Fellowship, 1993 - 1993
- Maulana Azad Medical CollegeClass of 1991
Certifications & Licensure
- PA State Medical License 2004 - 2026
- NJ State Medical License 2000 - 2023
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens.Brennan T Flannery, Howard M Sandler, Priti Lal, Michael D Feldman, Juan C Santa-Rosario
The Journal of Pathology. 2025-02-01 - Digital and Computational Pathology Applications in Bladder Cancer: Novel Tools Addressing Clinically Pressing Needs.João Lobo, Bassel Zein-Sabatto, Priti Lal, George J Netto
Modern Pathology. 2025-01-01 - 1 citationsDefining the cellular origin of seminoma by transcriptional and epigenetic mapping to the normal human germline.Keren Cheng, Yasunari Seita, Eoin C Whelan, Ryo Yokomizo, Young Sun Hwang
Cell Reports. 2024-06-25
Press Mentions
- Depleted Metabolic Enzymes Promote Tumor Growth in Kidney CancerMay 9th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: